CA2690011C - Dentifrice compositions for treating xerostomia - Google Patents

Dentifrice compositions for treating xerostomia Download PDF

Info

Publication number
CA2690011C
CA2690011C CA2690011A CA2690011A CA2690011C CA 2690011 C CA2690011 C CA 2690011C CA 2690011 A CA2690011 A CA 2690011A CA 2690011 A CA2690011 A CA 2690011A CA 2690011 C CA2690011 C CA 2690011C
Authority
CA
Canada
Prior art keywords
composition
microbial agent
surfactant
treatment
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2690011A
Other languages
French (fr)
Other versions
CA2690011A1 (en
Inventor
Shira Pilch
James G. Masters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colgate Palmolive Co
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of CA2690011A1 publication Critical patent/CA2690011A1/en
Application granted granted Critical
Publication of CA2690011C publication Critical patent/CA2690011C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43Guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Abstract

This invention encompasses an oral composition for treating or preventing dry mouth with following benefits: antibacterial/ anti-fungal efficacy, low irritancy, and moisture retention. The compositions can be a toothpaste, a mouth rinse or a spray and include one or more non-ionic surfactants, as foaming agents, one or more broad spectrum anti-microbial ingredient, such as chlorhexidine and cetylpyridinium chloride, and one or more oral surface adhesive polysaccharides that can encage cationic actives to help the deposition and retention of the agents onto oral surfaces and thus provide antimicrobial efficacy.

Description

TITLE OF THE INVENTION
DENTIFRICE COMPOSITIONS FOR TREATING XEROSTOMIA
BACKGROUND OF THE INVENTION
[0001] Dry mouth, clinically called xerostomia, is defined as a subjective feeling of dryness of the mouth. It is caused primarily by reduction of salivary secretion, but the underlying mechanism for such reduction varies from patient to patient.
Depending on its severity, dry mouth can cause discomfort and lead to pathological conditions, such as caries and fungal infection, specifically oral candidiasis.
[0002] Thus, there exists a need for a dentifrice composition having both oral hygiene and dry mouth prophylactic and therapeutic properties, as well as having the ability to be used as a treatment for such maladies.
[0003] Accordingly, the invention describes an oral composition for dry mouth relief with the following benefits anti-bacterial/anti-fungal property; low irritancy; and moisture retention.
SUMMARY OF THE INVENTION
[0004] The invention encompasses dentifrice compositions for treating or preventing dry mouth and which may also be used for the treatment or prevention of at least one associated pathology (such as a bacterial infection, a fungal infection or a protozoal infection).
In one embodiment, the compositions include one or more surfactants, one or more anti-microbial agents and one or more adhesives. The dentifrice compositions have oral hygiene treatment capabilities, as well as a prophylactic effect with regard to dry mouth, periodontal disease, and caries. In another embodiment, the invention encompasses a composition for use in the treatment or prevention of dry mouth, comprising at least one surfactant and at least one anti-microbial agent, wherein the at least one anti-microbial agent is sterically immobilized in a complex with one or more glycosaminoglycans. In another embodiment, the invention encompasses a composition for use in the treatment or prevention of dry mouth, comprising at least one surfactant and at least one anti-microbial agent, wherein the at least one anti-microbial agent is cetylpyridiniumchloride complexed with one or more glycosaminoglycans.
[0005] In another aspect, the invention encompasses a composition for use in the treatment of dry mouth comprising at least one surfactant, at least one anti-microbial agent, and at least one glycosaminoglycan polysaccharide; wherein the at least one anti-microbial agent is benzalkonium chloride, salicylanilide, domiphen bromide, cetylpyridiniumchlroide, tetradecylpyridinium chloride, N-tetra-decy1-4-ethylpyridinium chloride, octenidine, delmopinol, or octapinol.
DETAILED DESCRIPTION OF THE INVENTION
[0006] The invention encompasses a combination of antimicrobial and moisture retention agents, which composition has properties that provide dry mouth relief.
Surprisingly, it has been found that the dentifrice compositions described herein can sterically immobilize cationic antimicrobial actives by forming a cage-like structure to maintain the bioavailability of the actives and thereby provide efficient delivery to la the oral mucosa. The improved mucosal interaction can provide consumer perceived attributes due to the surface adhesion properties and surface coating of the compositions of the invention. The additional physical entrapment of the antimicrobial agent at the surface can lead to more substantive performance.
[0007] The present invention encompasses dentifrice compositions for alleviating or preventing xerostomia (i.e., dry mouth) and associated disorders of the oral cavity.
[0008] As used herein, term "dentifrice" or "dentifrices" refer to products which remain in the mouth for a relatively short period of time, in which they are intimately contacted with substantially all surfaces of the teeth, and are then removed. Non-limiting examples of such products include toothpastes, prophylactic pastes, tooth polishes, gels, professional gels and other related professional products, as well as mouth washes, sprays, mouth rinses, dental flosses, chewing gums, lozenges, tablets, edible food products, and the like.
[0009] In one embodiment, the compositions of the dentifrice of the present invention are toothpastes, mouth rinse, mouth sprays, and dental solutions. In another embodiment, the composition is toothpaste or a mouth rinse, and in another embodiment the dentifrice composition is toothpaste.
[0010] It has now been found that dry mouth and associated disorders of the oral cavity including cavity and infection, can be treated or prevented by administering an oral care dentifrice composition containing one or more non-ionic surfactants; one or more anti-microbial agents, and one or more adhesive polysaccharides.
[0011] Accordingly, the oral care dentifrice compositions of the invention are useful in dentifrice formulations and compositions in treating dry mouth and in the removal of plaque and calculus. While not intending to be held by any particular theory, it appears that the oral care dentifrice compositions can radically decrease, and even stop, dry mouth as well as plaque and calculus (tartar) buildup. It also appears that the oral care dentifrice compositions can stop the demineralization effect of caries and eliminate oral disease causing bacteria without detrimentally affecting the normal micro-flora in the mouth.
[0012] The dentifrice compositions of the invention include one or more surfactants or a mixture of compatible surfactants. Suitable surfactants are those which are reasonably stable throughout a wide pH range, for example, anionic, cationic, nonionic or zwitterionic surfactants. In an illustrative embodiment, the surfactant is a non-ionic surfactant useful as a foaming agent.
[0013] Suitable surfactants are described more fully, for example, in U.S. Pat. No.
3,959,458, to Agricola et al.; U.S. Pat. No. 3,937,807, to Haefele; and U.S.
Pat. No.
4,051,234, to Gieske et al.
[00141 In certain embodiments, anionic surfactants useful herein include the water-soluble salts of alkyl sulfates having from 10 to 18 carbon atoms in the alkyl radical and the water-soluble salts of sulfonated monoglycerides of fatty acids having from 10 to 18 carbon atoms. Sodium lauryl sulfate, sodium lauroyl sarcosinate and sodium coconut monoglyceride sulfonates are examples of anionic surfactants of this type. Mixtures of anionic surfactants may also be utilized.
[0015] In certain embodiments, the invention encompasses the use of non-ionic or zitterionic surfactants, such as betaine in pluronic in the place of SLS.
These surfactants are also reportedly associated with lower irritancy to oral mucosa comparing to SLS which may benefit dry mouth sufferers.
[0016] In another embodiment, cationic surfactants useful in the present invention may be derivatives of aliphatic quaternary ammonium compounds having one long alkyl chain containing 8 to 18 carbon atoms such as lauryl trimethylammonium chloride, cetyl pyridinium chloride, cetyl trimethylammonium bromide, di-isobutylphenoxyethyldimethylbenzylammonium chloride, coconut alkyltrimethylammonium nitrite, cetyl pyridinium fluoride, and mixtures thereof.
[0017] Illustrative cationic surfactants are the quaternary ammonium fluorides = described in U.S. Pat. No. 3,535,421, to Briner et al.
Certain cationic surfactants can also act as germicides in the compositions.
[0018] Illustrative nonionic surfactants that can be used in the compositions of the invention may be compounds produced by the condensation of alkylene oxide groups (hydrophilic in nature) with an organic hydrophobic compound which may be aliphatic or alkylaromatic in nature. Examples of suitable nonionic surfactants include, but are not limited to, the Pluronics, polyethylene oxide condensates of alkyl phenols, products derived from the condensation of ethylene oxide with the reaction product of propylene oxide and ethylene diamine, ethylene oxide condensates of aliphatic alcohols, long chain tertiary amine oxides, long chain tertiary phosphine oxides, long chain dialkyl sulfoxides and mixtures of such materials.
[0019] In certain embodiments, zwitterionic synthetic surfactants useful in the present invention may be derivatives of aliphatic quaternary ammonium, phosphomium, and sulfonium compounds, in which the aliphatic radicals can be straight chain or branched, and wherein one of the aliphatic substituents contains 8 to 18 carbon atoms and one contains an anionic water-solubilizing group, e.g., carboxy, sulfonate, sulfate, phosphate or phosphonate. Illustrative examples of the surfactants suited for inclusion into the composition include, but are not limited to, sodium alkyl sulfate, sodium lauroyl sarcosinate, cocoamidopropyl betaine and polysorbate 20, and combinations thereof.
[0020] The surfactant or mixtures of compatible surfactants can be present in the compositions of the present invention in an amount of about 0.1% to about 5.0%, in another embodiment about 0.3% to about 3.0% and in another embodiment about 0.5% to about 2.0% by weight of the total composition.
[0021] Antimicrobial and antibacterial agents included in the present dentifrice compositions may include, but are not limited to, triclosan (5-chloro-2-(2,4-dichlorophenoxy)-phenol); chlorhexidine; chlorhexidine digluconate (CHX);
alexidine, hexetidine (HEX); sanguinarine (SNG); bertzalkonium chloride;
salicylanilide.; domiphen bromide; cetylpyridiniumchloride (CPC);
tetradecylpyridinium chloride ([PC); N-tetra-decy1-4-ethylpyridinium chloride (IDEPC); octenidine; delmopinol; octapinol, and other piperidino derivatives;
nicin preparations; zinc/stannous ion agents; antibiotics such as augmentin, amoxicillin, tetracycline, deoxycycline, minocycline, and metronidazole; peroxide, such as cylium peroxide, hydrogen peroxide, and magnesium monoperthalate an its , 62301-2869 analogs; and analogs and salts of the above listed antimicrobial.
100221 In certain illustrative embodiments, the antifungal property can be provided by one of the broad spectrum antimicrobial agents, namely CHX and CPC, and agents specifically against fungal infections, such as Nystatin, Amphotericin B, and Natamycin. In certain embodiments, the compositions treat bacterial infections associated with dry mouth condition.
[0023] The antimicrobial or antibacterial agent may be present in the compositions of the present invention in an amount of about 0.1% to about 5.0%, in another embodiment in an amount of about 0.3% to about 3.0% and in another embodiment of about 0.5% to about 2.0% by weight of the total composition [0024] In order to provide a moisture retention property, other surface coating/moisture retaining polymers can also be incorporated in the composition.
The polymers include but not limited to the following families of compounds:
silicone oils (such as dimethicone, are known to provide surface coating and moisture retention properties in skin care), and polysaccharides (such as CMC, Xanthan, and Carbopol), hyaluronic acid, dermatan sulfate, chondrotin sulfate, heparin, heparan sulfate and keratin sulfate.
[0025] In order to assist the deliver of an antimicrobial agent, for example, CHX
and CPC, to oral surfaces, both compounds are sterically immobilized within one or combination of glycoaminoglycans (GAGs) molecule matrix by encapsulation or pre-emulsification before formulated in the final composition. They can form complex with GAGs through charge-charge interaction. GAG-Cl-DC or GAG-CPC complex can subsequently deposit and retain on oral surface via high surface adhesive property - of GAG. The deposited complex will slowly release CPC or CHX to provide antimicrobial effect.

=

[0025a] In an embodiment, the glycoaminoglycan is selected from the group consisting of hyaluronic acid, dermatan sulfate, chondrotin sulfate, heparin, heparan sulfate and keratin sulfate.
[0026] The polysaccharide may be present in the compositions of the present invention of about 0.1% to about 5.0%, in another embodiment of about 0.3% to about 3.0%
and in another embodiment of about 0.5% to about 2.0% by weight of the total composition.
[0027] A further component of the dentifrice composition of this invention are hydrophilic liquid vehicles, including but not limited to glycerin, propylene glycol, 5a polyethylene glycol, and hydrophobic liquid vehicles such as triglyceride, diglyceride, and organic oils including mineral oil, essential oils, and fatty vegetable oils. Essential oils, as used herein, are natural substances which are extracted via distillation from tiny molecular sacs of each boltanical, and are part of the plant's immune system and yet a separate substance created from the plant. The distillation process extracts the volatile oil from the plant parts. Such essential oils are highly concentrated extracts that contain hormones, vitamins and antiseptics that work on many levels. These hydrophilic and hydrophobic liquid vehicles can be used either singly or in combination and can be added in a proportion of of about 2 to about 50 wt. % (in the case of compositions including liquid vehicles), especially of about 10 to about 35 wt. % based on the whole composition.
[00281 Using one or more of these liquid vehicles, the composition of the present invention for the oral cavity may be formulated into a use form such as gel, liquid, or paste.
100291 The dentifrice composition of the invention also contains flavor components, typically in the form of natural flavors or aroma oils and/or herbal extracts and oils. These flavor components can serve not only to give a palatable flavor to the dentifrice composition, but can act as natural antibacterial agents and preservatives at the same time. The oils suitable for use in the present invention include, but are not limited to, citric oil, lemon oil, lime oil, lemongrass oil, orange oil, sweet orange oil, grapefruit oil, pomegranate oil, apricot oil extract, tangerine extract, tangelo oil, peppermint oil, spearmint oil, sage oil, rosemary oil, cinnamon oil, winter green oil, clove oil, eucalyptus oil, ginger oil, sassafras oil, menthol, arvensis mint oil, synthetic mint flavors and oils, carvone, eugenol, methyleugenol, methyl salicylate, methyl eugenol, thymol, anethole, millefolium extract, chamomile, lavender oil, myrrh, eugenol, tea tree oil, sage oil, mallow, limonene, ocimene, n-decyl alcohol, citronellol, alpha-terpineol, linalol, ethyllinalol, thyme, almond oil, nutmeg, and vanillin. Either one of these flavors or a mixture of two or more of these flavors can be used in the dentifrice composition. The dentifrice compositions of the present invention can also optionally contain sweeteners such as saccharin sodium, acesulfame potassium, glycyrrhizin, perillartine, thaumatin, aspartylphenylalanyl methyl ester and xylitol. The content thereof may be in an amount of about 3% to about 20% by weight, or about 4% to about 15% by weight, based on the total composition.
[00301 The dentifrice compositions may include one or more abrasives, which may be used in the practice of the invention including, but are not limited to, silica abrasives such as precipitated silicas having a mean particle size of up to about 20 microns, such as Zeodent 115 , marketed by J. M. Huber. The abrasive material should be one, which is compatible with the composition of interest and does not excessively abrade dentin. Suitable abrasives include for example, silicas including 'gels and precipitates; insoluble polymetaphosphate, hydrated alumina, resinous abrasives such as polymerized resins (e.g., ureas, melamines, cross-linked epoxides, phenolics, and the like), and mixtures thereof.
[0031] Useful abrasives also include sodium metaphosphate, potassium metaphosphate, tricalcium phosphate, dihydrated dicalciurn phosphate, aluminum silicate, calcined alumina, bentonite or other siliceous materials, or combinations thereof. The silica abrasives polishing materials useful herein, as well as the other abrasives, generally have an average particle size ranging between about 0.1 and 30 microns, from between 5 and 15 microns. The silica abrasives can be from precipitated silica or silica gels, such as the silica xerogels described in U.S. Pat. No.
3,538,230, to Pader et al. and U.S. Pat. No. 3,862,307, to Digiulio.
Particular silica xerogels are marketed under the trade name Syloid by the W. R. Grace & Co., Davison Chemical Division. The precipitated silica materials include those marketed by the J. M. Huber Corp. under the trade name Zeodent , including the silica carrying the designation Zeodent 115 and 119.
These silica abrasives are described in U.S. Pat. No. 4,340,583, to Wason .
[0032] Additional silica abrasives suitable for use with the present invention include but are not limited to silica gels, precipitated silicas, silicates, and hydrated silica. Silica gels suitable for use with the present invention are hydrogels, hydrous gels, xerogels, and aerogels, such as those known in the art and described in U.S. Pat.

No. 6,440,397. Precipitated silicas are those known in the art, such as the suitable dentifrice-type precipitated silicas described in U.S. Pat. No. 5,589,160.
Suitable silicates are any of those naturally occurring or synthetic silicates suitable for use with dentifrice compositions. These silica abrasives can be used singly or in combination. In certain embodiments, silica abrasive for use with the present invention includes silica gels. The silica abrasives can be used together with the calcium salt or in lieu of the calcium salt component.
100331 Water can optionally be incorporated into the present toothpaste compositions of the present invention. Water used in the preparation of commercially suitable toothpastes should be deionized and free of organic impurities. Water can generally includes about 0% to about 40% by weight of the compositions herein.
100341 The dentifrice compositions of the present invention can also optionally include anti-caries agents. Anti-caries agents are water-soluble fluoride ion sources.
The number of such fluoride ions sources is great and well known to those of skill in the art, and includes those disclosed in U.S. Pat. No. 3,535,421.
Fluoride ion source materials include sodium fluoride, potassium fluoride, sodium monofluorophosphate and mixtures thereof. A wide variety of fluoride ion-yielding materials can be employed as sources of soluble fluoride in the present compositions. Examples of suitable fluoride ion-yielding materials are found in U.S. Pat. No. 3,535,421, to Briner et al.; U.S. Pat.
No. 4,885,155, to Parran, jr. et al. and U.S. Pat. No. 3,678,154, to Widder et al.
10035] Representative fluoride ion sources include, but are not limited to, stannous fluoride, sodium fluoride, potassium fluoride, sodium monofluorophosphate, sodium fluorosilicate, sodium monfluorophosphate (MFP), ammonium fluorosilicate, as well as tin fluorides, such as stannous fluoride and stannous chloride, and combinations thereof. Certain particular embodiments include stannous fluoride or sodium fluoride as well as mixtures thereof.
=

[0036] In certain embodiments, the oral care strip or tape oral composition of the invention may also contain a source of fluoride ions or fluorine-providing ingredient in amounts sufficient to supply about 25 ppm to 5,000 ppm of fluoride ions.
[0037] Fluoride ion sources may be added to the compositions of the invention at a level of of about 0.01% to 3.0% in one embodiment or of about 0.03% to 1.0%, by weight of the composition in another embodiment. The dosage of the individual strip or tape (i.e., a single dose) is about 0.0001 to 0.003% by weight, 0.0005 to 0.003%
by weight, and in another embodiment about 0.001 to 0.02 % by weight.
[0038] Dentifrice compositions of the present invention can also optionally include one or more anticalculus (anti-tartar) agents. Anticalculus agents which may be useful in the dentifrice compositions of the present invention include antimicrobials such as chlorhexidine, niddamycin, and triclosan, metals and metal salts such as zinc citrate, Vitamin C, bisphosphonates, triclosanpyrophosphates, pyrophosphates, polyphosphates, polyacrylates and other polycarboxylates, polyepoxysuccinates, ethyenediaminetetraacetic acid (EDTA), nitrilotriacetic acid and related compounds, polyphosphonates, and polypyrophosphates such as sodium hexametaphosphate, as well as other anticalculus agents known to those of skill in the art, such as those described in K. J. Fairbrother et al., "Anticalculus agents," Journal of Clinical Periodontology Vol. 27, pp. 285 301 (2000).
10039] Nutrients and vitamins can also optionally be added to the dentifrice compositions of the present invention. Such agents can include folates, retinoids (Vitamin A), Vitamin B (Bi-thyamin, B2-riboflavin, B3-niacine, B5-pantothenic acid, B6-pyridoxine, 137-biotin, B8/ B9/ Bc-folic acid, B12-cyanocobalamin), Vitamin C
(ascorbic acid, sodium ascorbate), Vitamin E, Vitamin E analogs (d1-.alpha.-tocopherol acetate, tocopherol succinate, tocopherol nicotinate)and zinc.
[0040] A variety of miscellaneous additives can also be optionally formulated into the dentifrices of the present invention, such as tooth desensitizing agents (e.g., potassium and strontium salts), condensed anti-tartar agents such as sodium and potassium tetrapyrophosphate, whitening agents such as aluminum oxide and calcium peroxide, debriding agents such as sodium bicarbonate, pigments and dyes, such as Blue 15-C174160, Green 7-C174260, Reds 4-CI12085 and 40 CI16035, Yellows 115 C147005:1 and 5 CI19140, and Carmine 5 CI16035), as well as additives such as mica and sparkles. As with the other optional dentifrice additives, use can be made of either one of these ingredients or a mixture of two or more of these ingredients in amounts appropriate for the dentifrice composition.
[0041] In addition to the above-described components, the dentrif ice composition of the present invention can further contain a variety of optional ingredients and vehicles generally used for preparations for use in the oral cavity, such as dentifrices.
These optional components include, but are not limited to, such components as abrasives, surfactants, thickening agents, buffers, humectants, preservatives, and antibiotic and anti-caries agents. All of these additives, described in further detail below, are generally usual and would be known to one of skill in the art.
[0042] Another optional component of the dentifrice compositions of the present invention is a humectant. The humectant serves to keep compositions such as toothpaste compositions from hardening upon exposure to air, and to give mouthwash and toothpaste compositions a moist feel to the mouth. Certain humectants can also impart desirable sweetness of flavor to toothpaste and mouthwash compositions. Suitable humectants for use in compositions of the present invention include edible polyhydric alcohols such as glycerin, sorbitol, xylitol, polyethylene glycol, and propylene glycol.
[0043] Buffering agents are another optional component of the dentifrice compositions of the present invention. The buffering agents serve to retain the pH of the compositions within the range. Suitable buffering agents for use in dentifrice compositions of the present invention include soluble phosphate salts.
[0014] Other optional components of the dentifrice compositions of the present invention are preservatives, such as those that prevent microbial growth in the dentifrice compositions. Suitable preservatives include, but are not limited to, methylparaben, propylparaben, benzoates, and alcohols such as ethanol.
[0045] Binders and thickeners can also optionally be used in the dentifrice compositions of the present invention, particularly in toothpaste compositions. In certain embodiments, binders and thickening agents include, but are not limited to, carrageenan (e.g., Viscarin, Irish moss, and the like); cellulose derivatives such as hydroxyethyl cellulose, sodium carboxymethyl cellulose, and sodium carboxymethyl hydroxypropyl cellulose, carboxyvinyl polymers; natural gums such as karaya gum, gum Arabic, and tragacanth; polysaccharide gums such as xanthan gum; fumed silica; and colloidal magnesium aluminum silicate.
[0046] It has been unexpectedly found that the dentifrice composition of the present invention has the ability to reduce, treat or prevent dry mouth. The composition according to the present invention may be used by applying it into the oral cavity and brushing the teeth and/or gingivae. For such brushing, use of a toothbrush provided with plaque removing bristles and gingiva-massaging portions in combination, although a conventional toothbrush, namely, a toothbrush having plaque removing bristles or a toothbrush having massaging portions may also be used.
EXAMPLES
Example 1 [0047] Illustrative Example 1 provides a non-limiting example of a toothpaste formulation. The following ingredients were combined in the proportions described below:
redients % Wt./Wt.
Water 3.78 Sodium fluoride 0.26 Sodium saccharin 0.37 Sorbitol 67.1 Glycerine 7.46 PEG 600 1.5 Tetra sodium pyrophosphate 0.53 Xanthan 0.23 Carboxymethyl cellulose 0.8 Silica 12.5 Hyaluronic acid 0.5 Pluronic 1 Betaine surfactant 0.37 Flavor 1.1 Carboxymethyl cellulose 0.5 Dimethicone 2 Example 2 [0048] Illustrative Example 2 provides a non--limiting example of a mouth rinse formulation. The following ingredients were combined in the proportions given below:
Ingredients % Wt./Wt.
Water 84.41 Sodium saccharin 0.01 Glycerine 15 _ Hyaluronic acid 0.05 Carboxymethyl cellulose 0.08 Pluronic 0.1 Flavor 0.1 Cetyl pyridinium chloride 0.05 _ Dimethicone 0.2

Claims (24)

CLAIMS:
1. A composition for use in the treatment or prevention of dry mouth, comprising at least one surfactant and at least one anti-microbial agent, wherein the at least one anti-microbial agent is sterically immobilized in a complex with one or more glycosaminoglycans.
2. The composition of claim 1, wherein the composition is for use orally.
3. The composition of claim 1, wherein the composition is a toothpaste.
4. The composition of claim 1, wherein the composition is a mouthwash.
5. The composition of claim 1, wherein the composition is an oral spray.
6. The composition of any one of claims 1 to 5, for further use in the treatment or prevention of at least one pathology, which is a bacterial infection, a fungal infection, or a protozoal infection.
7. The composition of any one of claims 1 to 6, wherein the at least one surfactant is a non-ionic surfactant.
8. The composition of any one of claims 1 to 6, wherein the at least one surfactant is a cocoamidopropyl betaine.
9. The composition of any one of claims 1 to 8, wherein the at least one anti-microbial agent is 5-chloro-2-(2,4-diclorophenoxy)-phenol; chlorhexidine;
chlorhexidine digluconate; alexidine, hexetidine; sanguinarine; benzalkonium chloride;
salicylanilide;
domiphen bromide; cetylpyridiniumchloride; tetradecylpyridinium chloride; N-tetra-decyl-4-ethylpyridinium chloride; octenidine; delmopinol; octapinol, a nicin preparation; a zinc/stannous ion agent; augmentin; amoxicillin; tetracycline; deoxycycline;
minocycline;
metronidazole, cilium peroxide; hydrogen peroxide; or magnesium monoperthalate;
or a salt thereof.
10. The composition of any one of claims 1 to 9, wherein the at least one anti-microbial agent is chlorhexidine digluconate.
11. The composition of any one of claims 1 to 9, wherein the at least one anti-microbial agent is cetylpyridiniumchloride.
12. The composition of any one of claims 1 to 11, wherein the one or more glycosaminoglycans is selected from the group consisting of hyaluronic acid, dermatan sulfate, chondrotin sulfate, heparin, heparan sulfate and keratin sulfate.
13. The composition of any one of claims 1 to 11, wherein the one or more glycosaminoglycans is hyaluronic acid.
14. The composition of claim 1, wherein the composition further comprises at least one surface coating/moisture retaining polymer.
15. The composition of claim 14, wherein the at least one surface coating/moisture retaining polymer is a silicone oil or a polysaccharide.
16. The composition of any one of claims 1 to 15, wherein the composition further comprises at least one fluoride source.
17. The composition of any one of claims 1 to 16, wherein the composition further comprises at least one abrasive.
18. The composition of any one of claims 1 to 17, wherein the at least one anti-microbial agent comprises about 0.1 to about 5 wt.% of the composition.
19. The composition of any one of claims 1 to 18, wherein the at least one surfactant comprises about 0.1 to about 3 wt.% of the composition.
20. The composition of claim 1, wherein the at least one glycosaminoglycan comprises about 0.1 to about 3 wt.% of the composition.
21. A composition for use in the treatment of dry mouth comprising at least one surfactant, at least one anti-microbial agent, and at least one glycosaminoglycan; wherein the at least one anti-microbial agent is sterically immobilized in a complex with the at least one glycosaminoglycan and the at least one anti-microbial agent is benzalkonium chloride, salicylanilide, domiphen bromide, cetylpyridiniumchloride, tetradecylpyridinium chloride, N-tetra-decyl-4-ethylpyridinium chloride, octenidine, delmopinol, or octapinol.
22. A composition for use in the treatment or prevention of dry mouth, comprising at least one surfactant and at least one anti-microbial agent, wherein the at least one anti-microbial agent is cetylpyridiniumchloride complexed with one or more glycosaminoglycans.
23. The composition of claim 22, for further use in the treatment or prevention of at least one pathology, which is a bacterial infection.
24. The composition of claim 22, for further use in the treatment or prevention of at least one pathology, which is a fungal infection.
CA2690011A 2007-09-06 2008-07-17 Dentifrice compositions for treating xerostomia Expired - Fee Related CA2690011C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/850,955 US20090068122A1 (en) 2007-09-06 2007-09-06 Dentifrice Compositions for Treating Xerostomia
US11/850,955 2007-09-06
PCT/US2008/070285 WO2009032406A1 (en) 2007-09-06 2008-07-17 Dentifrice compositions for treating xerostomia

Publications (2)

Publication Number Publication Date
CA2690011A1 CA2690011A1 (en) 2009-03-12
CA2690011C true CA2690011C (en) 2015-03-31

Family

ID=39884915

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2690011A Expired - Fee Related CA2690011C (en) 2007-09-06 2008-07-17 Dentifrice compositions for treating xerostomia

Country Status (15)

Country Link
US (1) US20090068122A1 (en)
EP (1) EP2187885A1 (en)
JP (1) JP2010538074A (en)
CN (1) CN101795686A (en)
AR (1) AR068379A1 (en)
AU (1) AU2008296757C1 (en)
BR (1) BRPI0813970A2 (en)
CA (1) CA2690011C (en)
CO (1) CO6321137A2 (en)
MX (1) MX2009012775A (en)
MY (1) MY151338A (en)
RU (1) RU2452465C2 (en)
TW (1) TWI477269B (en)
WO (1) WO2009032406A1 (en)
ZA (1) ZA200908898B (en)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090053267A1 (en) * 2007-08-20 2009-02-26 Depierro Karen Dentifrice composition containing silicone oil beads
EP2303026B1 (en) 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US20100022471A1 (en) * 2008-07-23 2010-01-28 Sage Products Inc. Oral Moisturizer for Alleviating Dry Mouth
SG177474A1 (en) * 2009-07-31 2012-02-28 Colgate Palmolive Co High cleaning dentifrice compositions
US20110104080A1 (en) * 2009-11-03 2011-05-05 David Salloum Salloum Oral Compositions for Treatment of Dry Mouth
US20110104081A1 (en) * 2009-11-03 2011-05-05 Douglas Craig Scott Oral Compositions for Treatment of Dry Mouth
EP2506933A1 (en) * 2009-12-04 2012-10-10 Colgate-Palmolive Company Oral compositions containing extracts of garcinia mangostana l. and related methods
RU2012127804A (en) * 2009-12-04 2014-01-20 Колгейт-Палмолив Компани ORAL COMPOSITION CONTAINING EXTRACTS FROM MYRISTICA FRAGRANS, AND RELATED WAYS
AU2010326137B2 (en) * 2009-12-04 2013-05-30 Colgate-Palmolive Company Oral compositions containing extracts of Zizyphus joazeiro and related methods
JP2013512906A (en) * 2009-12-04 2013-04-18 コルゲート・パーモリブ・カンパニー Oral compositions containing combinations of natural extracts and related methods
MX341274B (en) * 2010-07-30 2016-08-12 Colgate-Palmolive Company * Mouthwash formulations for use with toothbrush delivery device.
SG190974A1 (en) 2010-12-23 2013-07-31 Colgate Palmolive Co Aqueous oral care composition comprising xanthan gum, cellulose gum and carbomer
CN102085369B (en) * 2011-01-28 2012-07-04 武汉耦合医学科技有限责任公司 Medical gel product for xerostomia and preparation method thereof
KR20140063616A (en) 2011-07-20 2014-05-27 브라이엄 영 유니버시티 Hydrophobic ceragenin compounds and devices incorporating same
US8697036B2 (en) * 2011-08-02 2014-04-15 The Procter & Gamble Company Process for surfactant taste and/or odor improvement
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
AU2012308530B2 (en) 2011-09-13 2016-04-21 Brigham Young University Products for healing of tissue wounds
JP6038154B2 (en) 2011-09-13 2016-12-07 ブリガム・ヤング・ユニバーシティBrigham Young University Composition for the treatment of bone disease and fractured bone
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
GB201121300D0 (en) * 2011-12-12 2012-01-25 Glaxo Group Ltd Novel composition
EP2793832B1 (en) 2011-12-21 2018-05-23 Brigham Young University Oral care compositions
US20140363780A1 (en) * 2011-12-21 2014-12-11 Brigham Young University Oral care compositions
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
EP3225113B1 (en) 2012-05-02 2020-09-02 Brigham Young University Methods for making ceragenin particulate materials
US10123953B2 (en) 2012-06-21 2018-11-13 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials
US9724542B2 (en) * 2012-10-12 2017-08-08 Premier Dental Products Company Remineralizing and desensitizing compositions, treatments and methods of manufacture
AU2013331136B2 (en) 2012-10-17 2016-05-12 Brigham Young University Treatment and prevention of mastitis
CN105451742B (en) 2013-01-07 2021-04-06 布莱阿姆青年大学 Methods for reducing cell proliferation and treating certain diseases
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
CA2907082C (en) 2013-03-15 2021-05-04 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US8815952B1 (en) * 2013-03-15 2014-08-26 Carnell & Herzog, LLC Chlorhexadine antiseptic
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
RU2525660C1 (en) * 2013-03-19 2014-08-20 государственное бюджетное образовательное учреждение высшего профессионального образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СтГМУ Минздрава России) Method of treating periodontal diseases
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
WO2015023226A1 (en) * 2013-08-16 2015-02-19 Exthera Ab Use of a composition comprising chitosan and a negatively charge polysaccharide for the treament of salivary dysfuntion
US20150099010A1 (en) 2013-10-07 2015-04-09 Reoxcyn Discoveries Group, Inc Redox signaling gel formulation
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
US10370403B2 (en) 2015-04-22 2019-08-06 Brigham Young University Methods for the synthesis of ceragenins
WO2016172553A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
CZ28634U1 (en) 2015-05-05 2015-09-14 Contipro Pharma A.S. Hyaluronan and octenidine dihydrochloride-based dental composition
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US10485827B2 (en) 2016-01-19 2019-11-26 Rdg Holdings, Inc. Topical eye serum compositions, methods or preparing, and methods of use
CN105748507B (en) * 2016-02-26 2018-04-17 陕西恒远生物科技有限公司 A kind of gelling agent for alleviating xerostomia
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US9474768B1 (en) 2016-05-18 2016-10-25 Reoxcyn Discoveries Group, Inc. Lubricant formulations
US11857674B2 (en) 2016-05-18 2024-01-02 Reoxcyn, Llc Lubricant formulations
KR20180006705A (en) 2016-07-11 2018-01-19 삼성전자주식회사 Pyridinium modified composite, and article including same
US9833471B1 (en) 2016-09-15 2017-12-05 Reoxcyn Discoveries Group, Inc. Hypochlorous acid-based hand sanitizer
US11458075B2 (en) * 2016-10-17 2022-10-04 Colgate-Palmolive Company Oral care composition having enhanced appearance and form
US20180200165A1 (en) 2017-01-16 2018-07-19 Reoxcyn Innovation Group, Llc Dentifrice formulations and methods of oral care
EP3366272B1 (en) * 2017-02-28 2019-10-30 Unilever PLC Oral care compositions
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
JP7455317B2 (en) * 2017-06-30 2024-03-26 小林製薬株式会社 Oral composition
IE87094B1 (en) * 2017-08-04 2020-05-13 Laboratorios Kin S A Gel comprising chlorhexidine
CN109381364A (en) * 2017-08-09 2019-02-26 杭州孚乐西生物技术有限公司 A kind of toothpaste containing sanguinarine
WO2019126703A1 (en) 2017-12-22 2019-06-27 Ecolab Usa Inc. Antimicrobial compositions with enhanced efficacy
CN110787078A (en) * 2018-08-20 2020-02-14 惠州市九惠制药股份有限公司 Toothpaste containing licoflavone and preparation method and application thereof
JP7140636B2 (en) * 2018-11-02 2022-09-21 アース製薬株式会社 Oral drug spray products
WO2020136620A1 (en) * 2018-12-29 2020-07-02 3M Innovative Properties Company Oral articles and methods of use
EP3941422A4 (en) * 2019-03-18 2023-04-19 Sunstar Americas, Inc. Oral care composition
CA3136627C (en) * 2019-04-10 2024-01-02 Black Tulip Management, Inc. Oral rinse compositions for reducing pathogens underlying and for treating periodontal disease and oral malodor in the canine
WO2020219323A1 (en) 2019-04-26 2020-10-29 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials
MX2021015126A (en) 2019-06-14 2022-01-24 Procter & Gamble Leave-on oral care compositions.
WO2020248232A1 (en) * 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions
BR112021024266A2 (en) 2019-06-14 2022-01-11 Procter & Gamble Compositions for rinse-free oral care
MX2021015129A (en) * 2019-06-14 2022-01-24 Procter & Gamble Leave-on oral care compositions.
WO2020248239A1 (en) * 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions
CN110840312B (en) * 2019-11-27 2021-05-11 铜陵麟安生物科技有限公司 Antibacterial and antivirus super-soft floor wet tissue and preparation method thereof
CN111662616A (en) * 2020-07-09 2020-09-15 周红岩 Thermosetting resin composition and application thereof
RU2761303C1 (en) * 2021-03-15 2021-12-07 Общество с ограниченной ответственностью "Дубна-Биофарм". Method for obtaining a pharmaceutical composition and a pharmaceutical composition for the treatment and prevention of periodontal diseases
DE102021108264A1 (en) 2021-03-31 2022-10-06 G. Pohl-Boskamp Gmbh & Co. Kg A composition for topical application to a subject

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678154A (en) * 1968-07-01 1972-07-18 Procter & Gamble Oral compositions for calculus retardation
US3535421A (en) * 1968-07-11 1970-10-20 Procter & Gamble Oral compositions for calculus retardation
US3959458A (en) * 1973-02-09 1976-05-25 The Procter & Gamble Company Oral compositions for calculus retardation
US3937807A (en) * 1973-03-06 1976-02-10 The Procter & Gamble Company Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies
US3862307A (en) * 1973-04-09 1975-01-21 Procter & Gamble Dentifrices containing a cationic therapeutic agent and improved silica abrasive
US4051234A (en) * 1975-06-06 1977-09-27 The Procter & Gamble Company Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies
US4233288A (en) * 1979-03-12 1980-11-11 Cornell John A Gum emulsified liquid package for delivering and preserving liquid content in the mouth
US4340583A (en) * 1979-05-23 1982-07-20 J. M. Huber Corporation High fluoride compatibility dentifrice abrasives and compositions
US4885155A (en) * 1982-06-22 1989-12-05 The Procter & Gamble Company Anticalculus compositions using pyrophosphate salt
IT1229075B (en) * 1985-04-05 1991-07-17 Fidia Farmaceutici Topical compsn. contg. hyaluronic acid deriv. as vehicle
US4945087A (en) * 1988-03-31 1990-07-31 Warner-Lambert Company Taste masking of thymol
SE9101076L (en) * 1991-04-10 1992-10-11 Camurus Ab SALIVERSAETTNINGSMEDEL
US5541165A (en) * 1994-09-27 1996-07-30 Turgeon; Jean A. Saliva substitute
US6159459A (en) * 1995-05-01 2000-12-12 Colgate Palmolive Company Oral lubricating composition
US5589160A (en) * 1995-05-02 1996-12-31 The Procter & Gamble Company Dentifrice compositions
US5658554A (en) * 1995-06-01 1997-08-19 Colgate-Palmolive Company Mouth moistener for the relief of dry mouth condition
US6294155B1 (en) * 1998-04-08 2001-09-25 W. R. Grace & Co. -Conn. Abrasive silica compositions and dentifrice compositions prepared therefrom
US6113629A (en) * 1998-05-01 2000-09-05 Micrus Corporation Hydrogel for the therapeutic treatment of aneurysms
EP1123695A3 (en) * 2000-01-28 2001-09-26 Unilever N.V. Oral composition comprising capsules containing keratin
ES2186569B1 (en) * 2001-09-28 2004-09-16 Lacer, S.A. COMPOSITIONS FOR THE RELIEF OF XEROSTOMY AND THE TREATMENT OF DISORDERS ASSOCIATED WITH THE SAME.
US6579513B1 (en) * 2002-01-03 2003-06-17 Playtex Products, Inc. Hygiene mouthspray composition
RU2220729C2 (en) * 2002-01-31 2004-01-10 Общество с ограниченной ответственностью "Научный Центр системных исследований и технологий 2000" Gel composition used in stomatology
IL165910A0 (en) * 2002-07-03 2006-01-15 Pericor Science Inc Compositions of hyaluronic acid and methods of use
PT1793799E (en) * 2004-08-02 2010-07-29 Glaxosmithkline Consumer Healt Novel composition for treating xerostomia
JP4836227B2 (en) * 2005-03-30 2011-12-14 Nsファーファ・ジャパン株式会社 Composition for preventing oral dryness and alleviating oral irritation
ITBO20050388A1 (en) * 2005-06-06 2006-12-07 Alfa Wassermann Spa USEFUL FORMULATION OF MUCOADESIVES IN MEDICAL DEVICES IN PHARMACEUTICAL PREPARATIONS
RU2286764C1 (en) * 2005-06-16 2006-11-10 Георгий Георгиевич Ростиашвили Agent of prolonged action for treatment of mouth cavity inflammation diseases

Also Published As

Publication number Publication date
CN101795686A (en) 2010-08-04
EP2187885A1 (en) 2010-05-26
US20090068122A1 (en) 2009-03-12
TW200927183A (en) 2009-07-01
AU2008296757A1 (en) 2009-03-12
BRPI0813970A2 (en) 2015-01-06
CA2690011A1 (en) 2009-03-12
AU2008296757C1 (en) 2012-02-02
RU2010112987A (en) 2011-10-20
AU2008296757B2 (en) 2011-06-23
ZA200908898B (en) 2014-11-26
MY151338A (en) 2014-05-15
MX2009012775A (en) 2009-12-10
RU2452465C2 (en) 2012-06-10
CO6321137A2 (en) 2011-09-20
WO2009032406A1 (en) 2009-03-12
JP2010538074A (en) 2010-12-09
AR068379A1 (en) 2009-11-11
TWI477269B (en) 2015-03-21

Similar Documents

Publication Publication Date Title
CA2690011C (en) Dentifrice compositions for treating xerostomia
US6235269B1 (en) Oral care compositions comprising chlorite and methods
AU2012396297B2 (en) Surfactant systems for zinc containing compositions
US6264924B1 (en) Oral care compositions comprising chlorite and methods
US6251372B1 (en) Oral care compositions comprising chlorite and methods
KR20160098260A (en) Oral care composition
KR20010070980A (en) Anti-inflammatory dental care agents
AU2016346191B2 (en) Oral care products and methods
KR20160096094A (en) Oral care composition comprising serine and at least a zinc salt
CA2399362C (en) Improved low-cost dentifrice composition
CA2754213C (en) Desensitizing dentifrice exhibiting dental tissue antibacterial agent uptake
WO2022133221A1 (en) Oral care compositions with amine flourides

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20220718